Literature DB >> 20075347

Therapeutic milestone: stroke declines from the second to the third leading organ- and disease-specific cause of death in the United States.

Amytis Towfighi1, Bruce Ovbiagele, Jeffrey L Saver.   

Abstract

BACKGROUND AND
PURPOSE: Stroke mortality rates declined for much of the second half of the 20th century, but recent trends and their relation to other organ- and disease-specific causes of death have not been characterized.
METHODS: Using the National Center for Health Statistics mortality data, leading organ- and disease-specific causes of death were assessed for the most recent 10-year period (1996 to 2005) in the United States with a specific focus on stroke deaths.
RESULTS: Age-adjusted stroke death rates declined by 25.4%; as a result, lung cancer (which only declined by 9.2%) surpassed stroke as the second leading cause of death in 2003. Despite a 31.9% decline in age-adjusted ischemic heart disease death rates, it remains the leading cause of death. Stroke is now the fifth leading cause of death in men and the fourth leading cause of death in whites but remains the second leading cause of death in women and blacks.
CONCLUSIONS: With stroke death rates decreasing substantially in the United States from 1996 to 2005, stroke moved from the second to the third leading organ- and disease-specific cause of death. Women and blacks may warrant attention for targeted stroke prevention and treatment because they continue to have disproportionately high stroke death rates.

Entities:  

Mesh:

Year:  2010        PMID: 20075347     DOI: 10.1161/STROKEAHA.109.571828

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  Association of BMI and cardiovascular risk stratification in the elderly African-American females.

Authors:  Fahad Javed; Emad F Aziz; Manpreet S Sabharwal; Girish N Nadkarni; Shahzeb A Khan; Juan P Cordova; Alexandre M Benjo; Dympna Gallagher; Eyal Herzog; Franz H Messerli; F Xavier Pi-Sunyer
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

2.  Why so negative about preventing cognitive decline and dementia? The jury has already come to the verdict for physical activity and smoking cessation.

Authors:  Leon Flicker; Teresa Liu-Ambrose; Arthur F Kramer
Journal:  Br J Sports Med       Date:  2010-09-28       Impact factor: 13.800

3.  The Affordable Care Act and stroke.

Authors:  Lesli E Skolarus; David K Jones; Lynda D Lisabeth; James F Burke
Journal:  Stroke       Date:  2014-07-01       Impact factor: 7.914

4.  Angiopoietin-like 4: A double-edged sword in atherosclerosis and ischemic stroke?

Authors:  Liang Xu; Zhen-Ni Guo; Yi Yang; Jun Xu; Sherrefa R Burchell; Jiping Tang; Jianmin Zhang; Jing Xu; John H Zhang
Journal:  Exp Neurol       Date:  2015-05-29       Impact factor: 5.330

5.  Determining stroke's rank as a cause of death using multicause mortality data.

Authors:  James F Burke; Lynda D Lisabeth; Devin L Brown; Matthew J Reeves; Lewis B Morgenstern
Journal:  Stroke       Date:  2012-07-19       Impact factor: 7.914

6.  Ethnic and geographic variation in stroke mortality trends.

Authors:  Richard F Gillum; John Kwagyan; Thomas O Obisesan
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

7.  Xenon-enhanced CT assessment of cerebral blood flow in stroke-in-progress patients with unilateral internal carotid artery or middle cerebral artery stenosis.

Authors:  Zhen-Ni Guo; Ge Yang; Hong-Wei Zhou; Jing Wang; Jiang Wu; Yi Yang
Journal:  Neurosci Bull       Date:  2013-09-09       Impact factor: 5.203

8.  Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke.

Authors:  William C Culp; Rene Flores; Aliza T Brown; John D Lowery; Paula K Roberson; Leah J Hennings; Sean D Woods; Jeff H Hatton; Benjamin C Culp; Robert D Skinner; Michael J Borrelli
Journal:  Stroke       Date:  2011-06-23       Impact factor: 7.914

Review 9.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

10.  The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.

Authors:  William Boland; Gwyn Bebb
Journal:  Biologics       Date:  2010-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.